In MASLD, however, lipid accumulation—via the peroxisome proliferator-activated receptor gamma (PPARg) pathway—drives conventional DCs (cDCs) toward a pro-inflammatory, antigen-presenting state. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.